Business
Nasodine Phase 3 Clinical Trial Surpasses 80% Recruitment
Nasodine Phase 3 Clinical Trial Surpasses 80% Recruitment
About this update from Firebrick Pharma Limited
[{"type":"text","content":"Firebrick Pharma Ltd has released a press release. View Attachment","length":252,"tagName":"div"}]